
Torrey Pines Investment
Description
Torrey Pines Investment, established in 2002 and headquartered in San Diego, California, is a specialized venture capital firm dedicated to the life sciences sector. The firm primarily focuses on early-stage companies within biotechnology, medical devices, diagnostics, and pharmaceuticals. With over two decades of experience, Torrey Pines Investment leverages the deep scientific and business expertise of its managing directors, Dr. David Kabakoff and Dr. Michael Kabakoff, to identify and nurture promising ventures in the highly complex and regulated life science industry.
The firm's investment strategy is characterized by its hands-on approach, aiming to be more than just a capital provider. Torrey Pines Investment actively engages with its portfolio companies, offering strategic guidance, operational support, and access to their extensive network. This collaborative model is designed to help early-stage companies navigate the challenges of product development, clinical trials, and market entry, ultimately accelerating their growth and increasing their probability of success. Their commitment extends to helping entrepreneurs transform innovative scientific discoveries into viable commercial products.
Torrey Pines Investment typically participates in seed and Series A funding rounds. For initial investments, the firm generally writes checks ranging from $500,000 to $2,000,000. This targeted investment size allows them to provide meaningful capital to nascent companies while maintaining a focused portfolio. According to Crunchbase, Torrey Pines Investment has made at least 13 investments since its inception, demonstrating a consistent commitment to the life science ecosystem.
The firm's long-standing presence in the San Diego biotech hub, a renowned cluster for life science innovation, provides them with a strategic advantage in sourcing deals and collaborating with key industry players. While their primary focus is on early-stage opportunities, their involvement often extends through subsequent funding rounds, supporting companies as they mature. Torrey Pines Investment's disciplined approach and specialized focus position them as a key partner for life science entrepreneurs seeking not only capital but also experienced guidance to bring their groundbreaking technologies to market.
Investor Profile
Torrey Pines Investment has backed more than 28 startups, with 6 new investments in the last 12 months alone. The firm has led 6 rounds, about 21% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Convertible Note rounds (top funding stages).
- Majority of deals are located in United States, Russian Federation, The Netherlands.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Led 2 rounds in the past year.
- Typical check size: $500K – $2M.
Stage Focus
- Seed (43%)
- Series Unknown (25%)
- Convertible Note (11%)
- Pre Seed (11%)
- Series B (7%)
- Series A (4%)
Country Focus
- United States (75%)
- Russian Federation (7%)
- The Netherlands (7%)
- Canada (4%)
- Finland (4%)
- Zambia (4%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Life Science
- Therapeutics
- Oncology
- Real Time
- Biopharma
- Fitness
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.